newsfilter
← Latest News
GlobeNewswire·

UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

RENO, Nev., May 27, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (NASDAQ:CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, today announced the launch of a